# US 2012/0252703 A1 · Method and system for capture and use of intact vesicles on electrodeposited hydrophobically modified biopolymer films

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252703 A1
- Document ID: US20120252703A1
- Status: Published application
- Kind: A1
- Application number: 13/310,579
- Filed: 2011-12-02
- Published: 2012-10-04
- Earliest claimed: 2010-12-02
- Assignees: University of Maryland, College Park Office of Technology Commercialization
- Inventors: Matthew Dowling; Srinivasa R. Raghavan; Neeraja Dashaputre; Douglas Stephen English; Vishal Javvaji; Gregory F. Payne; Philip R. DeShong
- Web page: https://patentgrep.com/patent/US20120252703A1

## CPC

- A61F 13/01017: {synthetic, e.g. polymer based}
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/44: Medicaments
- G01N 33/5432: {Liposomes or microcapsules}
- G01N 33/5436: {with ligand physically entrapped within the solid phase (liposomes G01N33/5432; immunological test elements G01N33/54386)}
- G01N 33/5438: {Electrodes}
- G01N 33/548: Carbohydrates, e.g. dextran
- A61L 2300/104: Silver, e.g. silver sulfadiazine
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/406: Antibiotics
- A61L 2300/414: Growth factors
- A61L 2300/626: Liposomes, micelles, vesicles
- Y10T 436/11: Automated chemical analysis
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A biosensor comprising an electrically conductive substrate coated with a modified chitosan biopolymer that has been electrodeposited on the substrate, wherein said modified chitosan biopolymer comprises at least one vesicle binding molecule. The biosensor is manufactured by a method where a modified chitosan biopolymer is electrodeposited on a substrate. The method is also used to manufacture a modified chitosan biopolymer film by electrodeposition of the chitosan on the substrate and later removing the film from the substrate after electrodeposition. The resulting film can be used in bandages to treat various types of wounds. The biosensor can also be used to detect various analytes in samples.

## Claims

### Claim 1

A biosensor, comprising:
an electrically conductive substrate coated with a modified chitosan biopolymer that has been electrodeposited on the substrate, wherein said modified chitosan biopolymer comprises at least one vesicle binding molecule.

### Claim 2 (depends on 2)

The biosensor of claim 2, wherein the modified chitosan electrodeposited on the substrate is selected from the group consisting of modified chitosan chloride, modified chitosan lactate, modified chitosan salicylate, modified chitosan pyrrolidone carboxylate, modified chitosan itaconate, modified chitosan niacinate, modified chitosan formate, modified chitosan acetate, modified chitosan gallate, chitosan glutamate, modified chitosan maleate, modified chitosan aspartate, modified chitosan glycolate and quaternary amine substituted chitosan and salts thereof.

### Claim 3 (depends on 2)

The biosensor of claim 2, wherein the vesicle binding molecule is a hydrophobic molecule or a molecule that recognizes a specific receptor on the vesicle's membrane.

### Claim 4 (depends on 1)

The biosensor of claim 1, wherein the substrate is an electrode.

### Claim 5 (depends on 4)

The biosensor of claim 4, wherein the electrode is selected from the group consisting of gold, silver, copper, platinum, palladium, Indium Tin Oxide (ITO) coated glass, and Tin Dioxide (SnO2) coated class electrodes.

### Claim 6 (depends on 4)

The biosensor of claim 4, wherein the electrode is on a chip.

### Claim 7 (depends on 5)

The biosensor of claim 5, wherein the chip is made of a material selected from the group consisting of silicon, copper oxide, germanium, gallium arsenide and grapheme.

### Claim 8 (depends on 1)

The biosensor of claim 1, further comprising at least one vesicle.

### Claim 9 (depends on 7)

The biosensor of claim 7, wherein the vesicle comprises a biological marker.

### Claim 10 (depends on 9)

The biosensor of claim 9, wherein the biological marker is selected from the group consisting of biotin, streptavidin, oligosaccharides, fluorescent markers.

### Claim 11 (depends on 1)

The biosensor of claim 1, wherein the substrate further comprises at least two electrode addresses.

### Claim 12 (depends on 11)

The biosensor of claim 11, wherein at least one of said at least two electrode addresses is coated with a first modified chitosan biopolymer that is different from a second modified chitosan biopolymer that coats another of said at least two electrode addresses.

### Claim 13 (depends on 11)

The biosensor of claim 11, wherein said first modified chitosan binds a first type of vesicle, while said second modified chitosan biopolymer binds a second type of vesicle.

### Claim 14

A method of manufacturing a biosensor, comprising:
electrodepositing a modified chitosan biopolymer on a substrate by applying voltage to the substrate, wherein the biopolymer is capable of coating the substrate upon application of electricity and wherein the modified chitosan biopolymer comprises at least one vesicle binding molecule.

### Claim 15 (depends on 14)

The method of claim 14, wherein prior to said electrodepositing step the substrate is placed in a solution of the modified chitosan polymer.

### Claim 16 (depends on 15)

The method of claim 15, wherein the chitosan is a modified chitosan salt selected from the group consisting of modified chitosan chloride, modified chitosan lactate, modified chitosan salicylate, modified chitosan pyrrolidone carboxylate, modified chitosan itaconate, modified chitosan niacinate, modified chitosan formate, modified chitosan acetate, modified chitosan gallate, modified chitosan glutamate, modified chitosan maleate, modified chitosan aspartate, modified chitosan glycolate and quaternary amine substituted modified chitosan and salts thereof.

### Claim 17 (depends on 14)

The method of claim 14, further comprising the step of attaching at least one vesicle to the biopolymer.

### Claim 18 (depends on 14)

The method of claim 14, wherein the substrate comprises at least two electrode addresses.

### Claim 19 (depends on 18)

The method of claim 18, further comprising the step placing the substrate in a solution containing a first type of modified chitosan biopolymer and applying voltage to a first set of electrode addresses in order to coat the first set of electrode addresses with the first type of modified chitosan biopolymer.

### Claim 20 (depends on 19)

The method of claim 19, further comprising the step placing the substrate in a solution containing a second type of modified chitosan biopolymer and applying voltage to a second set of electrode addresses in order to coat the second set of electrode addresses with the second type of modified chitosan biopolymer.

### Claim at position 21

21-35. (canceled)
